Estimation of VLDL, IDL, LDL, HDL<sub>2</sub>, apoA-I, and apoB from the Friedewald inputs—apoB and IDL, but not LDL, are associated with mortality in type 1 diabetes
Jaakko Niemi, Mika Ala‐Korpela(University of Oulu), Carol Forsblom(University of Helsinki), Markku J. Savolainen(Leiden University Medical Center), Per‐Henrik Groop(University of Helsinki), Minna L. Hannuksela(University of Oulu), Y. Antero Kesäniemi(University of Oulu), Leena Tenkanen, Ville‐Petteri Mäkinen(Helsinki University Hospital), Marja‐Riitta Taskinen(Hospital District of Helsinki and Uusimaa), Jukka Heikkonen, Kimmo Kaski(Aalto University), Petri T. Kovanen(Wihuri Research Institute), Yrjö Hiltunen(University of Eastern Finland), Matti Jauhiainen(Finnish Institute for Health and Welfare)
Cited by 39
Related Papers
Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel
|European Heart Journal|2017|3.8k
ESC/EAS Guidelines for the management of dyslipidaemias: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)
|European Heart Journal|2011|3.5k
Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: Consensus Statement of the European Atherosclerosis Society
|European Heart Journal|2013|2.7k
Lipoprotein(a) as a cardiovascular risk factor: current status
|European Heart Journal|2010|1.8k